Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 25, 2023

BUY
$49.72 - $54.64 $15 Million - $16.5 Million
301,484 Added 140.24%
516,454 $27.9 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $15 Million - $16.5 Million
301,484 Added 140.24%
516,454 $27.9 Million
Q1 2023

Sep 25, 2023

SELL
$45.09 - $50.03 $13.6 Million - $15.1 Million
-301,484 Reduced 58.38%
214,970 $10.8 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $8.99 Million - $9.97 Million
-199,290 Reduced 48.11%
214,970 $10.8 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $1.97 Million - $2.35 Million
49,696 Added 13.63%
414,260 $19.2 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $13.4 Million - $40 Million
364,564 New
364,564 $14.1 Million
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $4.86 Million - $5.41 Million
117,982 Added 182.12%
182,764 $7.93 Million
Q2 2021

Aug 17, 2021

BUY
$38.58 - $44.24 $2.5 Million - $2.87 Million
64,782 New
64,782 $2.77 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.